The board of directors of China Traditional Chinese Medicine Holdings Co. Limited announced that the executive Director, Mr. WANG Xiaochun, has been re-designated as the non-executive Director due to the change of his work arrangement, with effect from 25 November 2021. His roles as the deputy chairman of the Board, a member of the nomination committee of the Board and a member of the strategic committee of the Board remain the same. The Board announced that Mr. WANG has ceased to act as an authorised representative of the Company under Rule 3.05 of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited following his re-designation from an executive Director to a non-executive Director, and meanwhile, Mr. ZHAO Dongji, the joint company secretary of the Company, has been appointed as the Authorised Representative. Mr. WANG joined the Company since 23 October 2013 as an executive Director and a vice president of the Company and served as the Managing Director of the Company from March 2017 to July 2021. He serves as the Deputy Chairman of the Company from July 2021. Mr. WANG also serves as a non-independent director of Chongqing Taiji Industry (Group) Co. Ltd.